4 news items
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical's Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
ICU
7 Jun 24
in less ongoing tissue injury and improved tissue repair by rebalancing damaged tissue from a pro-inflammatory to a reparative/anti-inflammatory state
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
ICU
14 May 24
is approved for the treatment of pediatric patients with acute kidney injury (AKI) and sepsis or septic condition. Quelimmune has the potential to save
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
ICU
17 Apr 24
available for treating critically ill pediatric patients suffering from acute kidney injury (AKI) and sepsis. We are proud to be the only company
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
ICU
27 Mar 24
progress with our pivotal adult acute kidney injury (AKI) study with 23 subjects enrolled, including two additional subjects since our last update two
- Prev
- 1
- Next